SPY
QQQ
DIA
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Merck & Co., Inc.

MRK XNYS
$150.33 -1.83 (-1.20%) ▼ 15-min delayed
Open
$150.83
High
$152.22
Low
$150.09
Volume
4.40M
Market Cap
$370.89B

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 75.0K Website →

Key Financials

Period Revenue Net Income EPS
Q2 2026 $16.61B $-1,337,000,000 $-0.54
Q1 2026 $16.29B $-4,243,000,000 $-1.72
FY 2025 $65.01B $18.26B $7.30
Q3 2025 $17.28B $5.79B $2.32

Get MRK Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Merck & Co., Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.